| 01/31 | Rain Oncology to Participate in the 2023 Guggenheim Healthcare Talks Oncology Day Confe.. | AQ |
| 01/23 | Rain Oncology Inc. : Regulation FD Disclosure (form 8-K) | AQ |
| 01/23 | Phase 1 Clinical Data of Milademetan Published in Journal of Clinical Oncology | AQ |
| 01/23 | Rain Oncology Inc. Announces Phase 1 Clinical Data of Milademetan Publishes in Journal .. | CI |
| 01/23 | Mizuho Starts Rain Oncology at Buy With $18 Price Target | MT |
| 01/23 | Rain Oncology's Likely 'Positive Outcome' in Phase 3 Milademetan Study in Q1 Underpinni.. | MT |
| 01/11 | Transcript : Rain Therapeutics Inc. Presents at 41st Annual J.P. Morgan Healt.. | CI |
| 01/06 | Lifesci Capital Starts Rain Therapeutics at Outperform With $17 Price Target | MT |
| 01/05 | EF Hutton Initiates Rain Therapeutics at Buy With $16 Price Target | MT |
| 2022 | Rain Therapeutics Inc. will Change its Name to Rain Oncology Inc | CI |
| 2022 | Rain Therapeutics Inc. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, .. | AQ |
| 2022 | Rain Therapeutics to Change Name to Rain Oncology | MT |
| 2022 | Rain Therapeutics Inc. Announces Name Change to Rain Oncology Inc. | AQ |
| 2022 | Rain Therapeutics to Participate in the 41st Annual J.P. Morgan Health Care Conference | AQ |
| 2022 | Rain Therapeutics Inc.(NasdaqGS:RAIN) dropped from NASDA.. | CI |
| 2022 | Insider Buy: Rain Therapeutics | MT |
| 2022 | Citigroup Adjusts Price Target on Rain Therapeutics to $29 From $30, Maintains Buy Rati.. | MT |
| 2022 | Rain Therapeutics Announces a Poster Presentation at the 2022 San Antonio Breast Cancer.. | AQ |
| 2022 | Rain Therapeutics to Participate in Piper Sandler's 34th Annual Healthcare Conference | AQ |
| 2022 | Rain Therapeutics Announces an Oral Presentation at the Connective Tissue Oncology Soci.. | AQ |
| 2022 | Insider Buy: Rain Therapeutics | MT |
| 2022 | Rain Therapeutics to Participate in H.C. Wainwright's 3rd Annual Precision Oncology Vir.. | AQ |
| 2022 | Rain Therapeutics Inc. : Results of Operations and Financial Condition (form 8-K) | AQ |
| 2022 | Transcript : Rain Therapeutics Inc., Q3 2022 Earnings Call, Nov 10, 2022 | CI |
| 2022 | RAIN THERAPEUTICS INC. Management's Discussion and Analysis of Financial Condition and.. | AQ |
| 2022 | Rain Therapeutics Reports Third Quarter 2022 Financial Results and Highlights Recent Pr.. | AQ |
| 2022 | Rain Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months E.. | CI |
| 2022 | Insider Buy: Rain Therapeutics | MT |
| 2022 | Rain Therapeutics : Material Agreement - Form 8-K | PU |
| 2022 | Rain Therapeutics Inc. : Entry into a Material Definitive Agreement, Financial Statements .. | AQ |
| 2022 | Rain Therapeutics Prices $50 Million Offering; Shares Up | MT |
| 2022 | Rain Therapeutics Inc. : Regulation FD Disclosure (form 8-K) | AQ |
| 2022 | Rain Therapeutics Announces $50 Million Registered Offering of Common Stock | AQ |
| 2022 | Rain Therapeutics Provides Interim Analysis of Phase 2 Basket Trial of Milademetan for .. | AQ |
| 2022 | Rain Therapeutics Provides Interim Analysis of Phase 2 Basket Trial of Milademetan for .. | CI |
| 2022 | Rain Therapeutics to Report Third Quarter 2022 Financial Results and Highlights of Rece.. | AQ |
| 2022 | Rain Therapeutics Announces a Poster Presentation at the 34th EORTC/AACR/NCI Symposium | AQ |
| 2022 | HC Wainwright Initiates Rain Therapeutics at Buy With $10 Price Target | MT |
| 2022 | Transcript : Rain Therapeutics Inc. Presents at Citi's 17th Annual BioPharma .. | CI |
| 2022 | Rain Therapeutics to Participate in Citi's 17th Annual BioPharma Conference | AQ |
| 2022 | Transcript : Rain Therapeutics Inc., Q2 2022 Earnings Call, Aug 04, 2022 | CI |
| 2022 | RAIN THERAPEUTICS INC. Management's Discussion and Analysis of Financial Condition and.. | AQ |
| 2022 | Rain Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months E.. | CI |
| 2022 | Rain Therapeutics Reports Second Quarter 2022 Financial Results and Highlights Recent P.. | AQ |
| 2022 | Rain Therapeutics Completes Enrollment in Phase 3 Cancer Treatment Trial Five Months Ah.. | MT |
| 2022 | Rain Therapeutics Announces Completion of Enrollment in Phase 3 MANTRA Trial for Milade.. | AQ |
| 2022 | Rain Therapeutics Inc. Announces Completion of Enrollment in Phase 3 MANTRA Trial for .. | CI |
| 2022 | Rain Therapeutics to Report Second Quarter 2022 Financial Results and Highlights of Rec.. | AQ |
| 2022 | Rain Therapeutics Inc.(NasdaqGS:RAIN) dropped from Russe.. | CI |
| 2022 | Rain Therapeutics Inc.(NasdaqGS:RAIN) dropped from Russe.. | CI |
| 2022 | Rain Therapeutics Inc.(NasdaqGS:RAIN) dropped from Russe.. | CI |
| 2022 | Rain Therapeutics Inc.(NasdaqGS:RAIN) dropped from Russe.. | CI |
| 2022 | Rain Therapeutics Inc.(NasdaqGS:RAIN) dropped from Russe.. | CI |
| 2022 | Rain Therapeutics Inc.(NasdaqGS:RAIN) dropped from Russe.. | CI |
| 2022 | Rain Therapeutics Inc.(NasdaqGS:RAIN) dropped from Russe.. | CI |
| 2022 | Rain Therapeutics Inc.(NasdaqGS:RAIN) dropped from Russe.. | CI |
| 2022 | Rain Therapeutics Inc.(NasdaqGS:RAIN) dropped from Russe.. | CI |
| 2022 | Rain Therapeutics Inc.(NasdaqGS:RAIN) dropped from Russe.. | CI |
| 2022 | Rain Therapeutics Inc.(NasdaqGS:RAIN) dropped from Russe.. | CI |
| 2022 | Rain Therapeutics Inc.(NasdaqGS:RAIN) dropped from Russe.. | CI |
| 2022 | Rain Therapeutics Inc.(NasdaqGS:RAIN) dropped from Russe.. | CI |
| 2022 | Rain Therapeutics Inc.(NasdaqGS:RAIN) dropped from Russe.. | CI |
| 2022 | Rain Therapeutics Inc.(NasdaqGS:RAIN) dropped from Russe.. | CI |
| 2022 | Rain Therapeutics Inc.(NasdaqGS:RAIN) dropped from Russe.. | CI |
| 2022 | Rain Therapeutics Inc.(NasdaqGS:RAIN) dropped from Russe.. | CI |
| 2022 | JonesTrading Initiates Rain Therapeutics at Buy With $17 Price Target | MT |
| 2022 | Rain Therapeutics Inc.(NasdaqGS:RAIN) dropped from S&P G.. | CI |
| 2022 | Rain Therapeutics Inc. : Submission of Matters to a Vote of Security Holders (form 8-K) | AQ |
| 2022 | Roth Capital Starts Rain Therapeutics at Buy With $16 Price Target | MT |
| 2022 | Piper Sandler Adjusts Rain Therapeutics' Price Target to $12 From $26, Maintains Overwe.. | MT |
| 2022 | Rain Therapeutics Files $250 Million Mixed Shelf | MT |
| 2022 | Rain Therapeutics to Present on Milademetan at the 2022 American Society of Clinical On.. | AQ |
| 2022 | Transcript : Rain Therapeutics Inc., Q1 2022 Earnings Call, May 04, 2022 | CI |
| 2022 | RAIN THERAPEUTICS INC. Management's Discussion and Analysis of Financial Condition and.. | AQ |
| 2022 | Rain Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2.. | CI |
Google
Twitter
Facebook
Apple
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
